Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

DHR

Unveiling Insights on Danaher – Analyst Findings

Danaher logged a -2.2% change during today's morning session, and is now trading at a price of $195.09 per share.

Danaher returned losses of -24.7% last year, with its stock price reaching a high of $279.9 and a low of $171.0. Over the same period, the stock underperformed the S&P 500 index by -41.8%. AThe company's 50-day average price was $201.68. Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. Based in Washington, DC, the Large-Cap Industrials company has 61,000 full time employees. Danaher has offered a 0.6% dividend yield over the last 12 months.

Wider Gross Margins Than the Industry Average of 36.97%:

2019 2020 2021 2022 2023 2024
Revenue (M) $17,911 $22,284 $24,802 $26,643 $23,890 $23,875
Gross Margins 56% 56% 61% 61% 59% 60%
Net Margins 17% 16% 26% 27% 20% 16%
Net Income (M) $3,008 $3,646 $6,433 $7,209 $4,764 $3,899
Net Interest Expense (M) $108 $275 $231 $204 $286 $370
Depreciation & Amort. (M) $564 $637 $674 $698 $675 $721
Diluted Shares (M) 726 719 737 737 743 737
Earnings Per Share $4.05 $4.89 $8.61 $9.66 $6.38 $5.29
EPS Growth n/a 20.74% 76.07% 12.2% -33.95% -17.08%
Avg. Price $131.36 $183.49 $272.8 $269.24 $231.34 $199.44
P/E Ratio 31.96 36.92 31.11 27.47 35.92 37.42
Free Cash Flow (M) $3,316 $5,417 $7,118 $7,401 $5,781 $5,296
CAPEX (M) $636 $791 $1,240 $1,118 $1,383 $1,392
EV / EBITDA 24.58 29.36 30.33 25.12 31.1 29.0
Total Debt (M) $21,941 $21,215 $22,184 $20,268 $20,097 $16,510
Net Debt / EBITDA 0.53 3.12 2.78 1.73 2.42 2.58
Current Ratio 5.19 1.86 1.43 1.89 1.68 1.4

Danaher has growing revenues and increasing reinvestment in the business and wider gross margins than its peer group. Additionally, the company's financial statements display positive EPS growth and generally positive cash flows. Furthermore, Danaher has just enough current assets to cover current liabilities, as shown by its current ratio of 1.4 and significant leverage levels.

Danaher's Valuation Is in Line With Its Sector Averages:

Danaher has a trailing twelve month P/E ratio of 42.8, compared to an average of 24.03 for the Industrials sector. Based on its EPS guidance of $8.38, the company has a forward P/E ratio of 24.1. The 10.9% compound average growth rate of Danaher's historical and projected earnings per share yields a PEG ratio of 3.91. This suggests that these shares are overvalued. In contrast, the market is likely undervaluing Danaher in terms of its equity because its P/B ratio is 2.67 while the sector average is 2.89. The company's shares are currently trading 118.1% below their Graham number.

Danaher Has an Analyst Consensus of Strong Upside Potential:

The 20 analysts following Danaher have set target prices ranging from $205.0 to $310.0 per share, for an average of $245.5 with a buy rating. The company is trading -20.5% away from its average target price, indicating that there is an analyst consensus of strong upside potential.

Danaher has a very low short interest because 1.5% of the company's shares are sold short. Institutions own 82.7% of the company's shares, and the insider ownership rate stands at 11.05%, suggesting a large amount of insider shareholders. The largest shareholder is Vanguard Group Inc, whose 8% stake in the company is worth $11,855,538,505.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS